Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 78 clinical trials
RAMBLE - Rivaroxaban vs. Apixaban for Heavy Menstrual Bleeding

A large proportion of women with menstruating potential with newly diagnosed VTE or atrial fibrillation, treated with apixaban will have less menstrual blood loss than patients randomized to rivaroxaban.

rivaroxaban
apixaban
anticoagulation therapy
anticoagulants
  • 210 views
  • 23 Jan, 2021
  • 2 locations
Treatment of Post-STEMI Left Ventricular Thrombus With Optimized Anticoagulant

Left ventricular thrombus is a common complication subsequent to ST-segment elevation myocardial infarction (STEMI) that related to increased embolic events. This study aims to assess the efficacy and safety outcomes of Rivaroxaban on the treatment of post-STEMI left ventricular thrombus.

clot
stemi
troponin
angiography
warfarin
  • 0 views
  • 24 Jan, 2021
  • 1 location
Aspirin Plus Rivaroxaban Versus Rivaroxaban Alone for the Prevention of Venous Stent Thrombosis in Patients With PTS

To show if a combination therapy of rivaroxaban plus Aspirin is more efficient (superiority testing) as rivaroxaban alone in the prevention of early venous stent thrombosis in patients suffering from post-thrombotic syndrome in the first 6 months following endovascular therapy To demonstrate tolerability of combination therapy of Aspirin plus rivaroxaban …

clot
rivaroxaban
stenosis
blood clot
aspirin
  • 51 views
  • 24 Jan, 2021
A Nurse-coordinated Integrated Care Model for Patients With Atrial Fibrillation

This study aims to evaluate the effects of a nurse-coordinated, empowerment-based integrated care model on self-care behaviors and psychosocial outcomes in patients with atrial fibrillation (AF), and to explore how this intervention affects the self-care behaviors and quality of life from the patients' perspective. Stroke prevention by oral anticoagulants (OAC) …

anticoagulation therapy
anticoagulants
stroke
arrhythmia
vascular disease
  • 1 views
  • 27 Jan, 2021
  • 1 location
Biliary Tissue Sampling Using a Cytology Brush or the GIUM Catheter

Introduction In patients with a biliary obstruction, tissue is acquired immediately before drainage during endoscopic retrograde cholangio-pancreatography (ERCP). This is performed by passing a brush inside the bile duct stricture. However, brush cytology has a modest sensitivity (30-57%) for the diagnosis of cancer. A device, called the "G.I.U.M." catheter, allows …

cancer
obstruction
biliary obstruction
endoscopic retrograde cholangiopancreatography
drainage
  • 43 views
  • 07 Nov, 2020
  • 3 locations
The Preterm Infants' Paracetamol Study

Present randomized, controlled, double-blind trial investigates the efficacy and safety of early (<24 h) intravenous paracetamol therapy for pain medication in very small premature infants. This phase 2 drug study focuses on the efficacy and safety of short-term use. The pharmacokinetics and pharmacodynamics of paracetamol, as well as the long-term …

  • 0 views
  • 26 Jan, 2021
  • 1 location
An Observational Cohort Study to Investigate the Risk of Thromboembolic Events in Patients Receiving Kcentra or Plasma to Reverse Vitamin K Antagonist (VKA) Therapy in the Setting of Acute Major Bleeding

major bleeding in which patients are treated for Vitamin K antagonist reversal, the risk of thromboembolic events (TEE) in patients treated with Kcentra and in patients treated with plasma will be

  • 13 views
  • 24 Jan, 2021
  • 1 location
Stroke Prevention in Atrial Fibrillation Patients Between 2004 and 2020

Prevention of thromboembolic complications is an important part in the management of patients with atrial fibrillation (AF). European and American guidelines recommend the use of non-vitamin K

  • 0 views
  • 29 Jan, 2021
  • 2 locations
Risk of Recurrent Venous Thromboembolism After Provoked Venous Thromboembolism

further by prolonged anticoagulation is outweighed by the bleeding risk. However, the newer direct oral anticoagulants are potentially associated with a lower bleeding risk than vitamin K antagonists

  • 0 views
  • 23 Jan, 2021
  • 1 location
Benefit/Risk in Real Life of New Oral Anticoagulants and Vitamin K Antagonists in Patients Aged 80 Years and Over

(DOA) and with anti vitamin K (VKA) in older adults ( 80 years) suffering from non valvular atrial fibrillation and living in community or nursing home settings. An observational multicenter

rivaroxaban
fibrillation
vitamin k
warfarin
anticoagulants
  • 3 views
  • 23 Jan, 2021
  • 2 locations